Literature DB >> 29275830

Chronic tophaceous gout as the first manifestation of gout in two cases and a review of the literature.

Amir Bieber1, Naomi Schlesinger2, Abdallah Fawaz3, Reuven Mader4.   

Abstract

OBJECTIVES: Acute gout is a common arthritis that may eventually develop into chronic tophaceous gout (CTG). CTG usually is manifested by recurrent gout attacks. The diagnosis and treatment of CTG is challenging. Although the emergence of CTG without previous gout attacks is uncommon, it is important to recognize this unusual gout presentation.
METHODS: Herein, we present two cases of CTG, occurring in elderly patients with chronic kidney disease (CKD) on diuretics, who presented without a prior history of acute gout attacks. We also searched PUBMED, Ovid MEDLINE, and Google scholar (1970-2017), for "tophi as the initial manifestation of gout" and "chronic gout without previous attacks", and extracted relevant data.
RESULTS: The search disclosed one retrospective study and several case reports and case series describing 96 patients. Clinical and laboratory data was extracted from 34 patients. We found that a specific group of patients, e.g., elderly patients, most often female patients, suffering from CKD, and treated with diuretics, are specifically reported in the English medical literature to present with CTG as their first manifestation of gout.
CONCLUSION: The two cases and our literature review try to emphasize the many faces of chronic gout, in particular, its presentation without previous gout attacks.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Chronic tophaceous gout; Diuretics; Hyperuricemia

Mesh:

Year:  2017        PMID: 29275830     DOI: 10.1016/j.semarthrit.2017.11.006

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  1 in total

1.  Presence of tophi is associated with a rapid decline in the renal function in patients with gout.

Authors:  Yoon-Jeong Oh; Ki Won Moon
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.